108 related articles for article (PubMed ID: 35791393)
1. A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets.
Fu X; Ji F; He Q; Qiu X
J Immunol Res; 2022; 2022():5826741. PubMed ID: 35791393
[TBL] [Abstract][Full Text] [Related]
2. Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA.
Ye B; Shi J; Kang H; Oyebamiji O; Hill D; Yu H; Ness S; Ye F; Ping J; He J; Edwards J; Zhao YY; Guo Y
RNA Biol; 2020 Nov; 17(11):1666-1673. PubMed ID: 31607216
[TBL] [Abstract][Full Text] [Related]
3. ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation.
Huang Y; Chen D; Bai Y; Zhang Y; Zheng Z; Fu Q; Yi B; Jiang Y; Zhang Z; Zhu J
BMC Cancer; 2024 Apr; 24(1):452. PubMed ID: 38605349
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance and immunological role of HPRT1 in human cancers.
Lu Y; Chen R; Zhang H; Sun X; Li X; Yang M; Zhang X
Biomol Biomed; 2024 Mar; 24(2):262-291. PubMed ID: 38159260
[TBL] [Abstract][Full Text] [Related]
5. A pan-cancer analysis of the prognostic implication and oncogenic role of tubulin epsilon and delta complex 2 (TEDC2) in human tumors.
Liu Y; Zhu J; Shen J; Lu Y; Pan K; Tong C; Wang Y
Front Immunol; 2023; 14():1272108. PubMed ID: 38239349
[TBL] [Abstract][Full Text] [Related]
6. Activation of the YY1-UGT2B7 Axis Promotes Mammary Estrogen Homeostasis Dysregulation and Exacerbates Breast Tumor Metastasis.
Xu J; Zhou Y; He S; Wang Y; Ma J; Li C; Liu Z; Zhou X
Drug Metab Dispos; 2024 Apr; 52(5):408-421. PubMed ID: 38575184
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of PSME3: from pan-cancer analysis to experimental validation.
Dong C; Guo Y; Yang Y; Ge X
Front Immunol; 2024; 15():1295693. PubMed ID: 38312840
[TBL] [Abstract][Full Text] [Related]
8. Distinct roles of CD244 expression in cancer diagnosis and prognosis: A pan-cancer analysis.
Deng Z; Liu Y; Zhou H
Heliyon; 2024 Apr; 10(7):e28928. PubMed ID: 38633624
[TBL] [Abstract][Full Text] [Related]
9. Exploring the role of NAA40 in immune infiltrates and prognostic prediction in hepatocellular carcinoma.
Zhou T; Cao J; Tang Q; Jin J; Liang Y; Feng B
Am J Clin Exp Immunol; 2024; 13(1):26-34. PubMed ID: 38496356
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive pan-cancer analysis: essential role of ABCB family genes in cancer.
Xiao HN; Zhao ZY; Li JP; Li AY
Transl Cancer Res; 2024 Apr; 13(4):1642-1664. PubMed ID: 38737683
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome analysis reveals the clinical significance of CXCL13 in Pan-Gyn tumors.
Ding Y; Zhou Q; Ding B; Zhang Y; Shen Y
J Cancer Res Clin Oncol; 2024 Mar; 150(3):116. PubMed ID: 38459390
[TBL] [Abstract][Full Text] [Related]
12. The role of transcription factor Yin Yang-1 in colorectal cancer.
Shao Z; Yang W; Meng X; Li M; Hou P; Li Z; Chu S; Zheng J; Bai J
Cancer Med; 2023 May; 12(10):11177-11190. PubMed ID: 36880159
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between YY1 and lncRNAs in cancer: A review.
Wang XL; Li J; Cao YH
Medicine (Baltimore); 2022 Dec; 101(49):e31990. PubMed ID: 36626426
[TBL] [Abstract][Full Text] [Related]
14. A de novo YY1 missense variant expanding the Gabriele-de Vries syndrome phenotype and affecting X-chromosome inactivation.
Dos Santos SR; Piergiorge RM; Rocha J; Abdala BB; Gonçalves AP; Pimentel MMG; Santos-Rebouças CB
Metab Brain Dis; 2022 Oct; 37(7):2431-2440. PubMed ID: 35829845
[TBL] [Abstract][Full Text] [Related]
15. Systematic analysis of the prognosis and immune infiltration of E2Fs in thyroid carcinoma.
Fu X; Zhou X; Ji F; He Q; Qiu X
Front Genet; 2023; 14():1215984. PubMed ID: 37560385
[No Abstract] [Full Text] [Related]
16. CCND1-associated ceRNA network reveal the critical pathway of TPRG1-AS1-hsa-miR-363-3p-MYO1B as a prognostic marker for head and neck squamous cell carcinoma.
Li Z; Qiu X; He Q; Fu X; Ji F; Tian X
Sci Rep; 2023 Jul; 13(1):11831. PubMed ID: 37481637
[TBL] [Abstract][Full Text] [Related]
17. "Micro" Extrathyroidal Extension in Risk Stratification for Papillary Thyroid Carcinoma: Should It Be in the Intermediate-Risk or High-Risk Group? A Single-Center Retrospective Study.
He Q; Ji F; Fu X; Li Z; Qiu X
Cancer Manag Res; 2022; 14():3181-3190. PubMed ID: 36415538
[TBL] [Abstract][Full Text] [Related]
18. Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions.
Hosea R; Hillary S; Wu S; Kasim V
Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444616
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features and prognostic factors analysis of multiple synchronous distinct subtypes of primary thyroid carcinoma.
Dai Q; Fu X; Ding Y; He Q; Qiu X
Endocrine; 2023 Mar; 79(3):491-501. PubMed ID: 36399310
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors.
Zhu M; Wang X; Zhang Q; Xie C; Wang T; Shen K; Zhang L; Zhou X
Aging (Albany NY); 2024 Feb; 16(3):2563-2590. PubMed ID: 38315450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
